The present invention relates to compounds of Formula (I), processes for theirpreparation, pharmaceutical compositionscontaining them as active ingredient, methods for the treatment of diseasestates associated with angiogenesis, such as cancersassociated with protein tyrosine kinases, to their use as medicaments for usein the production of inhibition of tyrosine kinasesreducing effects in warm-blooded animals such as humans.
